• $47.5M
    Market Cap
  • -33.77%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
103.4M
-11.19%
116.4M
+18.18%
98.5M
-5.80%
104.6M
N/A
Cost of Revenue
63.5M
+5.32%
60.3M
+12.33%
53.7M
-5.15%
56.6M
N/A
Gross Profit
39.9M
-28.94%
56.1M
+25.18%
44.8M
-6.57%
48.0M
N/A
Sales and Marketing Expense
5.5M
-6.00%
5.8M
+8.14%
5.4M
+53.20%
3.5M
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
11.4M
-15.02%
13.4M
N/A
0
-100.00%
372,222
N/A
Total Operating Expenses
63.5M
+5.32%
60.3M
+12.33%
53.7M
-5.15%
56.6M
N/A
Operating Profit
-52.3M
+46.83%
-35.6M
-42.64%
-62.1M
+22.21%
-50.8M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-476,721
+43.12%
-333,082
N/A
N/A
N/A
-265,419
N/A
Interest Income and Expense and Net
-476,721
+43.12%
-333,082
N/A
0
+100.00%
-265,419
N/A
Total Nonoperating Income and Expense
7.0M
+7,835.96%
-90,586
-90.71%
-975,475
-52.08%
-2.0M
N/A
Income before Taxes
-52.3M
+46.83%
-35.6M
-42.64%
-62.1M
+22.21%
-50.8M
N/A
Income Taxes
11.6M
-4.48%
12.2M
+5.69%
11.5M
+31.78%
8.8M
N/A
Extraordinary Items
29.8M
+40.27%
21.3M
-54.58%
46.8M
+43.04%
32.8M
N/A
Net Income
-63.9M
+33.74%
-47.8M
-35.07%
-73.6M
+23.62%
-59.5M
N/A
Net Income from Continuing Operations Applicable to Common
-59.3M
+66.93%
-35.5M
-41.87%
-61.1M
+25.31%
-48.8M
N/A
Basic EPS and Net Income
-0.20
+25.00%
-0.16
-51.52%
-0.33
+22.22%
-0.27
N/A
Diluted EPS and Net Income
-0.20
+25.00%
-0.16
-51.52%
-0.33
+22.22%
-0.27
N/A
Basic Weighted Average Shares
325.3M
+11.35%
292.2M
+31.63%
222.0M
+2.48%
216.6M
N/A
Diluted Weighted Average Shares
325.3M
+11.35%
292.2M
+31.63%
222.0M
+2.48%
216.6M
N/A
Balance Sheet
Cash and Cash Equivalents
5.3M
-77.23%
23.4M
+97.65%
11.8M
-69.50%
38.8M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
5.3M
-77.23%
23.4M
+97.65%
11.8M
-69.50%
38.8M
N/A
Total Current Assets
41.1M
-24.24%
54.3M
+14.77%
47.3M
-16.90%
56.9M
N/A
Accumulated Depreciation
19,704
-30.80%
28,472
-99.93%
40.8M
+41.74%
28.8M
N/A
Property and Plant and Equipment and Net
34.1M
-46.27%
63.5M
-5.98%
67.6M
-5.48%
71.5M
N/A
Total Long-Term Assets
829,164
-19.79%
1.0M
+18.84%
869,853
+0.85%
862,545
N/A
Total Assets
152.3M
-26.34%
206.7M
+36.24%
151.7M
-31.04%
220.1M
N/A
Income Taxes Payable
665,916
-63.45%
1.8M
-78.04%
8.3M
+92.27%
4.3M
N/A
Total Short-Term Debt
9.8M
+12.31%
8.7M
+882.09%
884,000
0.00%
884,000
N/A
Total Current Liabilities
23.1M
-8.71%
25.3M
+65.78%
15.3M
-0.55%
15.4M
N/A
Total Long-Term Debt
15.1M
+26.82%
11.9M
+1,248.54%
884,000
0.00%
884,000
N/A
Total Long-Term Liabilities
1.3M
+2.43%
1.2M
+3,599.16%
33,000
+17.86%
28,000
N/A
Total Liabilities
101.2M
+7.58%
94.0M
+113.17%
44.1M
+3.19%
42.7M
N/A
Retained Earnings
-320.0M
+24.96%
-256.1M
+22.94%
-208.3M
+54.65%
-134.7M
N/A
Total Stockholders Equity
51.1M
-54.64%
112.7M
+4.71%
107.6M
-39.30%
177.3M
N/A
Total Shares Outstanding
325.7M
+0.16%
325.2M
+45.61%
223.3M
+1.29%
220.5M
N/A
Cash Flow
Cash from Operating Activities
-14.2M
-372.35%
5.2M
+143.26%
-12.0M
+78.09%
-6.8M
N/A
Capital Expenditures
6.6M
-45.44%
12.0M
+43.50%
8.4M
-49.66%
16.7M
N/A
Cash from Investing Activities
2.5M
+166.82%
-3.8M
-58.83%
-9.2M
-35.14%
-14.2M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.8M
-73.21%
6.7M
+2,614.90%
-267,529
-123.42%
1.1M
N/A
Financials Ratio
Gross Margin
38.57%
-19.98%
48.20%
+5.93%
45.50%
N/A
N/A
N/A
Operating Margin
-50.57%
+65.33%
-30.59%
-51.46%
-63.02%
N/A
N/A
N/A
Return on Assets
-35.61%
+33.54%
-26.67%
-32.65%
-39.59%
N/A
N/A
N/A
Return on Equity
-78.03%
+79.87%
-43.38%
-16.03%
-51.66%
N/A
N/A
N/A
Revenue Growth
-11.19%
-161.59%
18.18%
+413.17%
-5.80%
N/A
N/A
N/A
Current Ratio
1.78
-17.02%
2.14
-30.77%
3.09
N/A
N/A
N/A
Cash Ratio
0.23
-75.06%
0.92
+19.23%
0.77
N/A
N/A
N/A
Debt-to-Equity Ratio
0.49
+166.08%
0.18
+1,014.63%
0.02
N/A
N/A
N/A
Debt-to-Assets Ratio
0.16
+63.79%
0.10
+752.14%
0.01
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow